MedTrace Logo

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.

NCT00785850 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2009-03-06

No results posted yet for this study

Summary

To prove the safety in normal conditions of use.

Conditions

  • Hygiene

Interventions

DRUG

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00785850 on ClinicalTrials.gov